Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
09/2012
09/04/2012US8258288 RNA interference mediated inhibition of respiratory syncytial virus (RSV) expression using short interfering nucleic acid (siNA)
09/04/2012US8258262 N-terminally chemically modified protein compositions and methods
09/04/2012US8258261 Induction of tumor immunity by variants of folate binding protein
09/04/2012US8258143 Methods of using substituted pyrrolo[2,3-d]pyrimidines for targeting tumor cells and treating cancer
09/04/2012US8258119 Anti-cancer drugs and uses relating thereto for metastatic malignant melanoma and other cancers
09/04/2012US8258118 4-pyridinone compounds and their use for cancer
09/04/2012US8258106 Immunostimulatory nucleic acid molecules
09/04/2012US8258098 Antitumoral treatments
09/04/2012US8257931 Regulation of protein synthesis
09/04/2012US8257708 Antibodies against cancer antigen TMEFF2 and uses thereof
09/04/2012US8257683 Multilayer binding; lamellar surface structure containing at least two binding compounds is assembled under conditions in which the binding compounds self-regulate in or on the lamellar structure; organized mobile multifunctional conjugate (OMMC) assembly
09/04/2012CA2656578C Tyrosine kinase inhibitors
09/04/2012CA2513276C Compositions containing coenzyme q10
09/04/2012CA2510531C Compositions of magnetic particles covered with gem-bisphosphonate derivatives
09/04/2012CA2506716C Carboxamides
09/04/2012CA2432971C Polypeptides
08/2012
08/30/2012WO2012116357A2 Use of agr3 for treating cancer
08/30/2012WO2012116288A1 2-amino-naphthyridine derivatives
08/30/2012WO2012116277A1 Cannabinoid receptor modulators
08/30/2012WO2012116272A2 Polymer conjugated protein micelles
08/30/2012WO2012116247A1 Hsp90 inhibitory compounds in treating jak/stat signaling-mediated cancers
08/30/2012WO2012116225A2 Muc1 based glycolipopeptide vaccine with adjuvant
08/30/2012WO2012116196A2 Substituted lactosyl compounds and use thereof for cellular imaging and therapy
08/30/2012WO2012116151A2 Substituted aromatic sulfur compounds and methods of their use
08/30/2012WO2012116061A1 Combination therapy of hsp90 inhibitory compounds with radiotherapy
08/30/2012WO2012116050A2 Phosphorus containing compounds as protein kinase inhibitors
08/30/2012WO2012115446A2 Compound based on 5-(substituted alkyl-aminomethyl) isoxazole acting as a t-type calcium channel antagonist
08/30/2012WO2012115437A2 Pharmaceutical composition for cancer treatment or metastasis inhibition containing expression or activation inhibitors of map7d2 protein, novel cancer therapeutic target
08/30/2012WO2012115402A2 Crystalline form of docetaxel and process for preparation thereof
08/30/2012WO2012115286A1 Alpha helix mimetics and methods relating thereto
08/30/2012WO2012115241A1 Fcγriib-specific fc antibody
08/30/2012WO2012115226A1 Therapeutic agent for cancer
08/30/2012WO2012115209A1 Soluble epoxide hydrolase inhibitor
08/30/2012WO2012113920A1 Arylsulfone derivatives with activity against human betaherpesviruses
08/30/2012WO2012113897A1 Antitumoral combination comprising cabazitaxel and cisplatin
08/30/2012WO2012113835A1 C-glucosidic ellagitannin compounds for use for altering the supramolecular arrangement of actin and for the treatment of osteoporosis, cancer, bacterial infection and viral infection
08/30/2012WO2012113774A1 Thiazolylphenyl-benzenesulfonamido derivatives as kinase inhibitors
08/30/2012WO2012113572A1 Ketogenic diet composition for the treatment of chemo therapy and/or radiation therapy patients
08/30/2012WO2012113571A1 Bisphosphonate-prodrugs
08/30/2012WO2012113415A1 Ketogenic diet composition for the treatment of chemo therapy and/or radiation therapy patients
08/30/2012WO2012113266A1 Antibody and antigen recognizing tumor-initiating cells and use thereof
08/30/2012WO2012113064A1 Method of diagnosing primary mediastinal b-cell lymphoma or classical hodgkin lymphoma by detecting functional mutation at ciita locus.
08/30/2012WO2012113061A1 Cancer diagnosis and treatment
08/30/2012WO2012094540A3 Methods for preparation of glycosphingolipids and uses thereof
08/30/2012WO2012062904A3 Compositions and methods for the prevention and treatment of cancer
08/30/2012WO2012062901A3 Chromene derivatives and their analoga as wnt pathway antagonists
08/30/2012WO2012054929A3 Use of human serum albumin to decrease antigenicity of therapeutic proteins
08/30/2012WO2012050398A3 Pharmaceutical composition including herbal medicine extract for preventing or treating lung cancer
08/30/2012WO2012050397A3 Pharmaceutical composition including herbal medicine extract for preventing or treating kidney cancer
08/30/2012WO2012050396A3 Pharmaceutical composition including herbal medicine extract for preventing or treating liver cancer
08/30/2012US20120222142 Gut flora-derived extracellular vesicles, and method for searching for a disease model, vaccine, and candidate drug and for diagnosis using the same
08/30/2012US20120220922 Photolabile compounds
08/30/2012US20120220921 Immunologically modified carbon nanotubes for cancer treatment
08/30/2012US20120220672 Presence of ERG Gene Rearrangements and Protein Over-expression in Low Grade PIN (LG-PIN) in Prostate Biopsies
08/30/2012US20120220666 Composition to enhance the bioavailability of curcumin
08/30/2012US20120220664 Use of metformin in cancer treatment and prevention
08/30/2012US20120220662 Phytoceutical compositions for pets
08/30/2012US20120220659 Medicament having promoting action on hepatocyte proliferation
08/30/2012US20120220657 Synergistic anti-inflammatory and antioxidant dietary supplement compositions
08/30/2012US20120220647 Nano-hybrid of targetable sirna-layered inorganic hydroxide, manufacturing method thereof, and pharmaceutical composition for treating tumor comprising the nano-hybrid
08/30/2012US20120220646 Treatment of Cancer by Inhibition of IGFBPs and Clusterin
08/30/2012US20120220645 Genetic changes in atm and atr/chek1 as prognostic indicators in cancer
08/30/2012US20120220644 Use of two microrna moleculars in lung cancer prognosis and medicine preparation
08/30/2012US20120220640 Methods of treating diseases
08/30/2012US20120220634 Taxane Compounds, Compositions And Methods
08/30/2012US20120220633 Piperidine derivatives as human papilloma virus inhibitors
08/30/2012US20120220631 USE OF 5H-THIOENO(3,4-c)PYRROLE-4,6-DIONE DERIVATIVES AS TUMOR NECROSIS FACTOR INHIBITOR
08/30/2012US20120220621 Anti-cancer compound and pharmaceutical composition containing the same
08/30/2012US20120220618 Anticancer agent sensitivity-determining marker
08/30/2012US20120220615 Substituted indolyl alkyl amino derivatives as novel inhibitors of histone deacetylase
08/30/2012US20120220613 Method for determining sensitivity to an anticancer agent
08/30/2012US20120220611 1,3-benzoxazolyl derivatives as kinase inhibitors
08/30/2012US20120220610 Inhibitions of glutaminase c
08/30/2012US20120220602 Cysteine protease inhibitors
08/30/2012US20120220600 N-Oxide of 3-(2,6-dichloro-3,5-dimethoxy-phenyl) -1--1-methyl-urea
08/30/2012US20120220595 Deuterated Tyrosine Kinase Inhibitors
08/30/2012US20120220594 Methods for treating cancer in patients having igf-1r inhibitor resistance
08/30/2012US20120220591 Pyrimidone compounds
08/30/2012US20120220587 Pyridinylimidazolone derivatives for the inhibition of pi3 kinases
08/30/2012US20120220586 Heterocyclic compounds and their uses
08/30/2012US20120220585 Heterocyclic compounds and their uses
08/30/2012US20120220584 Heterocyclic compounds and methods of use
08/30/2012US20120220582 Imidazopyrazine syk inhibitors
08/30/2012US20120220576 Novel Heterocyclic Derivatives
08/30/2012US20120220575 N-substituted oxazinopteridines and oxazinopteridinones
08/30/2012US20120220573 Benzodiazepine Bromodomain Inhibitor
08/30/2012US20120220572 Tricyclic inhibitors of kinases
08/30/2012US20120220570 Fused heterocyclic ring derivative and use thereof
08/30/2012US20120220569 Fused heterocyclic ring derivative and use thereof
08/30/2012US20120220563 Substituted piperidines
08/30/2012US20120220561 Oxadiazole inhibitors of leukotriene production
08/30/2012US20120220558 Methods of Treating Hormone-Related Conditions Using Thio-Oxindole Derivatives
08/30/2012US20120220551 Phosphorus containing compounds as protein kinase inhibitors
08/30/2012US20120220548 Compositions and methods for treatment of virus-associated cancer cells
08/30/2012US20120220546 Compostions designed for the inhibition and/or blocking of the epithelial/mesenchymal transition
08/30/2012US20120220540 Synbodies to akt1
08/30/2012US20120220539 Conotoxin peptides
08/30/2012US20120220538 Lunasin-containing complex and purification of lunasin from plants
08/30/2012US20120220537 9-aminoacridine derivatives, their preparation and uses
08/30/2012US20120220526 Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and other Disorders
1 ... 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 ... 2211